DNA damaging properties of G-quadruplex ligand QN-302 are potentiated by the DNA repair inhibitor Olaparib and mitigated by the molecular helicase PhpC.

QN-302 - Qualigen Therap

Lynparza (olaparib) - Merck (MSD), AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/41965726

Angélique Pipier; David Monchaud; Garance Psalmon; Manon Barbotte; Robert H E Hudson; Stephen Neidle

Apr 12, 2026